• Deutsch
  • English
  • Magyar


Transurethral prostate hyperthermia

Schema der Prostatahypethermie
Scheme of Prostate Hyperthermia

Hyperthermia treatments for prostate problems or illnesses have been established as one of the most successful therapies at our center. The key treatment is a transurethral hyperthermia and as an important addition a short series of mild - moderate whole body hyperthermia treatments. Your individual treatment will be carefully planned based on the symptoms and present findings.

Prostatitis (prostate inflammation):

A cure for this disease - often young men - can be can be difficult. In to 90 percent (!) of inflammation of the prostate is – according to a publication of the German Medical Journal – the inflammation is not caused by bacteria, so antibiotics are not indicated [1]. Our multimodal therapy approach with hyperthermia and natural healing substances has proven to be very effective in chronic prostatitis.

Symptoms of prostatitis may include pain in the lower abdomen and back, problems with urination, feeling of pressure in the perineal area, pain during intercourse and also an elevated PSA level. Therapeutically antibiotics are indicated in the (rare) bacterial prostate inflammation, in non-bacterial prostatitis whole body hyperthermia, local deep hyperthermia of the prostate, a prostate thermal therapy and an individual orthomolecular approach based on laboratory analysis with anti-inflammatory and immune modulating substances can be very helpful.

[1] Dtsch Arztebl Int. 2009 Mar;106(11):175-83. Epub 2009 Mar 13.

Prostatic hyperplasia (prostate enlargement)

In benign prostate enlargement, which in extreme cases may result in surgery or wearing of a catheter, we were able to achieve impressive results with hyperthermia treatment.

Benign prostatic hyperplasia is a common disease in men aged 50 years with an approximate incidence of every 10th man. It is caused by nodes (adenomas) that grow in different sizes and often push onto the urethra or the bladder. This results in frequent urination and the weakening of the urinary flow.

Prostate Cancer

As long as the cancer is confined to the prostate, a complete cure is possible. Five years after the initial therapy 80% of patients are alive today when the tumor is detected early; if it is confined to the prostate, more than 90%. In order to remove the tumor almost reflexively surgery (prostatectomy) or radiation therapy has been suggested and implemented. This results in the risk of side effects such as incontinence and erectile dysfunction.

More and more often today gentle methods, as well as a wait and see attitude (watch & wait) - especially in the elderly - have its place and will be chosen instead of the invasive method such as prostatectomy. Many men do so - after careful education and treatment planning - the method of local prostate hyperthermia in combination with some temporary hormonal therapy and comprehensive rehabilitation program in orthomolecular medicine - with good success. But also in combination with radiation therapy, hyperthermia offers a valuable synergy - Hyperthermia enhances the oxygen partial pressure in cancer tissues, thus increasing the sensitivity to ionizing radiation.

If a biopsy of the prostate is required?

Using modern diagnostic tools early prostate biopsy can be avoided:

The following techniques are to be performed in addition to the known PSA testing:

  • PCA3 testing in urine:
  • Analysis of circulating tumor cells from the blood
  • MRI of the prostate with spectroscopy

Only when these method cannot conclusively prove prostate cancer, and a suspicion of carcinoma remains, in these rare cases, a biopsy is performed.

Thus, only in cases where surgery is planned and the surgeon insists on it biopsy is performed.

PCA3 test in urine

In the search for new diagnostic methods for prostate cancer, a molecule (a so-called "non-encoded RNA") was discovered, which is present in prostate cancer cells in almost 100 times higher concentration than in normal prostate cells

After a medical palpation of the prostate prostate cancer cells are released including existing cells in the urine, where they can then be detected. As with almost all diagnostic tests solely the PCA-3 test, even if it is low, provides no 100% guarantee that no prostate cancer is present.

The test is much more specific than the traditional PSA level and also not influenced by the prostate gland size.

Analysis of circulating tumor cells in blood

Using a modified test system for PCR detection of tumor-specific gene expression blood is analyzed on the presence of free circulating tumor cells.

Circulating epithelial cells can be enriched by Magnetic bead separation from the blood.

Thereafter real-time PCR measures the expression of six epithelial genes and a control gene.

The quantitative analysis of gene expression allows direct conclusions on the number of free circulating tumor cells in the body.

Prostate MRI scan with magnetic resonance spectroscopy

This MRI scan increased as a result of the individual measurements, the diagnostic accuracy of up to 90%. Not only location, size and extent of tumors are detected more precisely but also with respect to the tumor stage, low, medium and high Gleason scores are determined.

The different resonant properties of molecules in a strong magnetic field can be used for analysis and representation of tissues. Based on the different resonance frequencies single molecular constituents of tissues are identified and quantified. Measurement of citrate and choline:

  • Citrate is produced from healthy prostate tissue. Since citrate is used in prostate tissue for energy consumption the intracellular citrate content of prostate tissue decreases in various from prostate diseases.
  • Choline is a component of the cell membrane and in malignant prostate diseases increased, associated with cell proliferation.

Prostate cancer should therefore be recognized by a Citrate lowering and Choline rising.